ES2898511T3

Pd-1-binding molecules and methods of use thereof

Abstract

An anti-human PD-1 binding monospecific monoclonal antibody comprising a variable heavy chain domain and a variable light chain domain, wherein: said variable heavy chain domain comprises the amino acid sequence of SEQ ID NO: 147, and said variable light chain domain comprises the amino acid sequence of SEQ ID NO: 153.

ES2898511T3, drawing sheet 1 — Sheet 1 of 38

Term

9.8 yearsto projected expiry

Projected expiry 28 July 2036, counted from filing; an application has no term until it is granted.

38 sheets

Sheet 1
Sheet 2
Sheet 3
Sheet 4
Sheet 5
Sheet 6
Sheet 7
Sheet 8
Sheet 9
Sheet 10
Sheet 11
Sheet 12
Sheet 13
Sheet 14
Sheet 15
Sheet 16
Sheet 17
Sheet 18
Sheet 19
Sheet 20
Sheet 21
Sheet 22
Sheet 23
Sheet 24
Sheet 25
Sheet 26
Sheet 27
Sheet 28
Sheet 29
Sheet 30
Sheet 31
Sheet 32
Sheet 33
Sheet 34
Sheet 35
Sheet 36
Sheet 37
Sheet 38

160 members in 43 offices

This recordMember, by publication datePriority claim33 more offices are in the list below

Priority claims9

Priority claims
Document	Office	Kind	Date
201562198867P	United States of America	–	2015-07-30
201562198867	United States of America	P	2015-07-30
201562239559P	United States of America	–	2015-10-09
201562239559	United States of America	P	2015-10-09
201562255140P	United States of America	–	2015-11-13
201562255140	United States of America	P	2015-11-13
201662322974P	United States of America	–	2016-04-15
201662322974	United States of America	P	2016-04-15
2016044430	United States of America	W	2016-07-28

Members160

Family members, oldest first
Document	Office	Kind
CA2993948A1	Canada	A1	2017-02-02
WO2017019846A1	World Intellectual Property Organization (WIPO)	A1	2017-02-02
TW201710292A	Taiwan Province of China	A	2017-03-16
JOP20200213A1	Jordan	A1	2017-06-16
AR105520A1	Argentina	A1	2017-10-11
ZA201800500A0	South Africa	A0	2018-01-24
WO2017019846A8	World Intellectual Property Organization (WIPO)	A8	2018-01-25
AU2016298227A1	Australia	A1	2018-02-22
AU2016298227A8	Australia	A8	2018-03-08
MX2018001227A	Mexico	A	2018-03-26
CN107847574A	China	A	2018-03-27
IL257216D0	Israel	D0	2018-03-29
KR20180034588A	Republic of Korea	A	2018-04-04
CO2018000867A2	Colombia	A2	2018-04-19
ECSP18006831A	Ecuador	A	2018-04-30
CR20180062A	Costa Rica	A	2018-05-25
EP3328419A1	European Patent Office (EPO)	A1	2018-06-06
PE20181151A1	Peru	A1	2018-07-17
CL2018000254A1	Chile	A1	2018-07-20
KR20180093127A	Republic of Korea	A	2018-08-20
PH12018500232A1	Philippines	A1	2018-08-29
AU2018214151A1	Australia	A1	2018-08-30
JP2018524394A	Japan	A	2018-08-30
EA201890296A1	Eurasian Patent Organization (EAPO)	A1	2018-08-31
AU2016298227A2	Australia	A2	2018-09-13
HK1248106A	Hong Kong, China	A	2018-10-12
HK1248106A1	Hong Kong, China	A1	2018-10-12
CN108976300A	China	A	2018-12-11
EP3328419A4	European Patent Office (EPO)	A4	2018-12-26
EP3456346A1	European Patent Office (EPO)	A1	2019-03-20
JP2019055948A	Japan	A	2019-04-11
US2019127467A1	United States of America	A1	2019-05-02
MX2019001161A	Mexico	A	2019-07-04
SG10201906059VA	Singapore	A	2019-08-27
AU2016298227B2	Australia	B2	2019-10-03
MA47137A	Morocco	A	2019-10-30
AU2016298227B9	Australia	B9	2019-10-31
AU2018214151B2	Australia	B2	2019-10-31
AU2020200054A1	Australia	A1	2020-01-30
US10577422B2	United States of America	B2	2020-03-03
TWI691509B	Taiwan Province of China	B	2020-04-21
US2020231675A1	United States of America	A1	2020-07-23
TW202028234A	Taiwan Province of China	A	2020-08-01
EA202090579A1	Eurasian Patent Organization (EAPO)	A1	2020-09-30
ZA201807856B	South Africa	B	2020-09-30
ZA201800500B	South Africa	B	2020-10-28
SG10202010506TA	Singapore	A	2020-11-27
CR20200423A	Costa Rica	A	2021-01-20
JO3736B1	Jordan	B1	2021-01-31
MA42542A	Morocco	A	2021-05-26
EP3456346B1	European Patent Office (EPO)	B1	2021-07-07
EP3328419B1	European Patent Office (EPO)	B1	2021-08-25
DK3456346T3	Denmark	T3	2021-08-30
MA47137B1	Morocco	B1	2021-08-31
LT3456346T	Lithuania	T	2021-09-27
PT3456346T	Portugal	T	2021-09-28
MA42542B1	Morocco	B1	2021-09-30
DK3328419T3	Denmark	T3	2021-10-11
RS62374B1	Serbia	B1	2021-10-29
JP6959897B2	Japan	B2	2021-11-05
JP6959907B2	Japan	B2	2021-11-05
LT3328419T	Lithuania	T	2021-11-10
SMT202100527T1	San Marino	T1	2021-11-12
SMT202100610T1	San Marino	T1	2021-11-12
HRP20211333T1	Croatia	T1	2021-11-26
PT3328419T	Portugal	T	2021-11-26
HUE055207T2	Hungary	T2	2021-11-29
MD3456346T2	Republic of Moldova	T2	2021-11-30
SI3328419T1	Slovenia	T1	2021-11-30
SI3456346T1	Slovenia	T1	2021-11-30
PL3456346T3	Poland	T3	2021-12-20
PL3328419T3	Poland	T3	2021-12-27
RS62568B1	Serbia	B1	2021-12-31
IL287916A	Israel	A	2022-01-01
IL287916D0	Israel	D0	2022-01-01
JP2022002540A	Japan	A	2022-01-11
MY188871A	Malaysia	A	2022-01-11
MD3328419T2	Republic of Moldova	T2	2022-01-31
AR120117A2	Argentina	A2	2022-02-02
HRP20211645T1	Croatia	T1	2022-02-04
AU2022200168A1	Australia	A1	2022-02-10
HUE056201T2	Hungary	T2	2022-02-28
IL257216A	Israel	A	2022-03-01
IL257216B	Israel	B	2022-03-01
AU2020200054B2	Australia	B2	2022-03-03
ES2898511T3This record	Spain	T3	2022-03-07
ES2898958T3	Spain	T3	2022-03-09
IL290571A	Israel	A	2022-04-01
IL290571D0	Israel	D0	2022-04-01
EP3981792A1	European Patent Office (EPO)	A1	2022-04-13
TWI762879B	Taiwan Province of China	B	2022-05-01
GEAP202215554A	Georgia	A	2022-06-10
CR20220194A	Costa Rica	A	2022-06-16
CN114773475A	China	A	2022-07-22
CY1124634T1	Cyprus	T1	2022-07-22
CY1124723T1	Cyprus	T1	2022-07-22
GEAP202214712A	Georgia	A	2022-07-25
TW202229357A	Taiwan Province of China	A	2022-08-01
GEP20227419B	Georgia	B	2022-10-10
IL290571B	Israel	B	2022-11-01

Showing 100 of 160

Pd-1-binding molecules and methods of use thereof

Abstract

Term

Priority claims9

Members160

Numbers

Titles2

Classification